Hologic Inc. (HOLX)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS
CEO:
Stephen P. MacMillan
Employees:
6,478
250 CAMPUS DRIVE, MARLBOROUGH, MA 01752
5082632900

Hologic, Inc. engages in the development, manufacture and supply diagnostics products, medical imaging systems and surgical products dedicated to serve the healthcare needs of women. The company operates through four business segments: Breast Health, Diagnostics, GYN Surgical and Skeletal Health. The Breast Health segment products include a broad portfolio of breast imaging and related products and accessories, including digital and film-based mammography systems, magnetic resonance imaging, breast coils, computer-aided detection for mammography and MRI, minimally invasive breast biopsy devices, breast biopsy site markers, breast biopsy guidance systems, breast imaging comfort pads, and breast brachytherapy products. It has also developed a new breast imaging platform, Dimensions, which utilizes a new technology, tomosynthesis, to produce three dimensional images, as well as conventional two dimensional full field digital mammography images. The Diagnostics segment products include the ThinPrep system, which is primarily used in cytology applications such as cervical cancer screening, the Rapid Fetal Fibronectin Test, which assists physicians in assessing the risk of pre-term birth, and its molecular diagnostic reagents used for a variety of DNA and RNA analysis applications based on its proprietary Invader chemistry. Its current molecular diagnostic offerings based upon this Invader chemistry include Cervista HPV high risk and Cervista HPV 16/18 products to assist in the diagnosis of human papillomavirus, as well as other products to diagnose cystic fibrosis, cardiovascular risk and other diseases. The GYN Surgical segment products include the NovaSure Endometrial Ablation System and the MyoSure Hysteroscopic Tissue Removal System. The MyoSure system is a tissue removal device that is designed to provide incision-less removal of fibroids and polyps within the uterus. The Skeletal Health segment products include dual-energy X-ray bone densitometry systems, an ultrasound-based osteoporosis assessment product, and Fluoroscan mini C-arm imaging products. The company was founded by S. David Ellenbogen and Jay A. Stein in October, 1985 and is headquartered in Bedford, MA.

Data derived from most recent annual or quarterly report
Market Cap 18.659 Billion Shares Outstanding253.487 Million Avg 30-day Volume 1.438 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 85.0 / 60.1 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from HOLX instead.

View recent insider trading info

Funds Holding HOLX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HOLX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MACMILLAN STEPHEN P CHAIRMAN, PRESIDENT AND CEO

  • Officer
  • Director
2,182,967 2021-09-25 5

HELLMANN ELISABETH A SVP, HUMAN RESOURCES

  • Officer
6,945 2021-09-25 2

COHN BENJAMIN JORDAN PRINCIPAL ACCOUNTING OFFICER

  • Officer
20,106 2021-08-10 7

GRIFFIN JOHN M. GENERAL COUNSEL

  • Officer
123,600 2021-08-09 6

VERSTREKEN JAN GROUP PRESIDENT, INTERNATIONAL

  • Officer
44,669 2021-07-01 5

DAUGHERTY SEAN S. GROUP PRESIDENT, BSH & SURG.

  • Officer
26,613 2021-05-10 5

CRAWFORD SALLY

  • Director
133,380 2021-03-11 1

GARRETT SCOTT T

  • Director
69,064 2021-03-11 2

DOCKENDORFF CHARLES J

  • Director
28,662 2021-03-11 1

WENDELL AMY MCBRIDE

  • Director
21,183 2021-03-11 1

HANTSON LUDWIG

  • Director
11,545 2021-03-11 1

STAMOULIS CHRISTIANA

  • Director
45,925 2021-03-11 2

NAWANA NAMAL

  • Director
20,246 2021-03-11 1

BEBO ALLISON P SVP, HUMAN RESOURCES

  • Officer
35,680 2021-02-05 5

THORNAL KEVIN R DIV. PRESIDENT, DIAGNOSTICS

  • Officer
33,216 2020-12-10 5

OBERTON KARLEEN MARIE CHIEF FINANCIAL OFFICER

  • Officer
57,078 2020-12-01 3

VALENTI PETER J. III DIVISION PRES., BREAST HEALTH

  • Officer
59,991 2020-06-30 0

WEST THOMAS A. DIV PRESIDENT & GM, DIAGNOSTIC

  • Officer
55,753 2018-12-01 0

MCMAHON ROBERT W. CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2018-08-02 0

COMPTON ERIC B. COO

  • Officer
107,560 2017-12-01 0

ULLIAN ELAINE

  • Director
27,302 2017-11-13 0

LEVY LAWRENCE M

  • Director
32,615 2017-10-10 0

COUGHLIN CHRISTOPHER J

  • Director
7,633 2017-03-08 0

LEAMING NANCY

  • Director
No longer subject to file 2017-03-08 0

MERKSAMER SAMUEL J.

  • Director
No longer subject to file 2016-03-02 0

CHRISTODORO JONATHAN

  • Director
No longer subject to file 2016-03-02 0

LAVANCE DAVID R JR

  • Director
9,362 2016-02-24 0

WILSON WAYNE

  • Director
42,487 2016-01-01 0

STEIN JAY A CHIEF TECHNICAL OFFICER

  • Officer
201,648 2015-11-18 0

EGSTRAND CLAUS SVP AND GM, INTERNATIONAL

  • Officer
3,150 2015-11-05 0

ICAHN CARL C

HIGH RIVER LIMITED PARTNERSHIP

ICAHN PARTNERS LP

ICAHN PARTNERS MASTER FUND LP

  • 10% Owner
  • NO LONGER SUBJECT TO SEC. 16
No longer subject to file 2015-08-04 0

CASEY MARK J SVP, CAO, GC & SECRETARY

  • Officer
14,725 2014-11-18 0

MILLS ROGER D. GSVP & GM SERVICE & OPERATIONS

  • Officer
58,823 2014-11-07 0

HASTIE ROHAN GROUP SVP & GM DIAGNOSTICS

  • Officer
2,857 2014-08-06 0

MUIR GLENN P EXECUTIVE VP AND CFO

  • Officer
815,306 2014-05-08 0

LAVALLEE ROBERT H SVP, CHIEF ACCOUNTING OFFICER

  • Officer
11,341 2014-05-06 0

ICAHN CARL C

  • 10% Owner
34,154,879 2013-12-12 0

CUMMING JOHN W PRESIDENT AND CEO

  • Officer
0 2013-11-18 0

HARDING DAVID GROUP VP & GM, WOMEN'S HEALTH

  • Officer
0 2013-11-18 0

BRADY DAVID J SVP, HUMAN RESOURCES

  • Officer
0 2013-11-18 0

CASCELLA ROBERT CEO AND PRESIDENT

  • Officer
  • Director
401,438 2013-07-01 0

SOLTANI PETER SVP & GM, WOMEN'S HEALTH

  • Officer
42,625 2013-06-28 0

HULL CARL SVP AND GM OF DIAGNOSTICS

  • Officer
61,674 2013-02-01 0

WILLIAMSON STEVE S SVP, GYN SURGICAL

  • Officer
41,721 2012-03-07 0

MYSLINSKI MARK D SVP, DIAGNOSTICS

  • Officer
0 2011-01-31 0

PEKARSKY JOHN R SVP, SALES & STRATEGIC ACCOUNT

  • Officer
No longer subject to file 2010-06-28 0

DORAN HOWARD JR SVP, DIAGNOSTICS PRODUCTS

  • Officer
38,602 2010-03-12 0

KINGSLEY STUART A SVP, GYN SURGICAL

  • Officer
36,032 2009-11-13 0

MCDANIEL C WILLIAM

  • Director
63,660 2008-06-13 0

SULLIVAN PATRICK J EXECUTIVE CHAIRMAN

  • Officer
  • Director
No longer subject to file 2008-05-28 0

LERNER ARTHUR G

  • Director
No longer subject to file 2008-01-07 0

FAJARDO LAURIE

  • Director
No longer subject to file 2008-01-03 0

LEVANGIE DANIEL J

  • Director
256 2007-12-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HELLMANN ELISABETH A - Officer SVP, HUMAN RESOURCES

2021-10-20 16:22:46 -0400 2021-08-30 G 441 d 6,945 direct -0.0407 0.0 1 -0.0407 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
HOLOGIC INC HOLX 2021-10-25 22:15:03 UTC -0.18 0.25 9200000
HOLOGIC INC HOLX 2021-10-25 21:45:03 UTC -0.18 0.25 9200000
HOLOGIC INC HOLX 2021-10-25 21:15:03 UTC -0.18 0.25 9200000
HOLOGIC INC HOLX 2021-10-25 20:45:03 UTC -0.18 0.25 9200000
HOLOGIC INC HOLX 2021-10-25 20:15:03 UTC -0.18 0.25 9200000
HOLOGIC INC HOLX 2021-10-25 19:45:04 UTC -0.18 0.25 9200000
HOLOGIC INC HOLX 2021-10-25 19:15:03 UTC -0.18 0.25 9200000
HOLOGIC INC HOLX 2021-10-25 18:45:02 UTC -0.18 0.25 9200000
HOLOGIC INC HOLX 2021-10-25 18:15:03 UTC -0.18 0.25 9200000
HOLOGIC INC HOLX 2021-10-25 17:45:03 UTC -0.18 0.25 9200000
HOLOGIC INC HOLX 2021-10-25 17:15:03 UTC -0.18 0.25 9200000
HOLOGIC INC HOLX 2021-10-25 16:45:02 UTC -0.18 0.25 9200000
HOLOGIC INC HOLX 2021-10-25 16:15:03 UTC -0.18 0.25 9200000
HOLOGIC INC HOLX 2021-10-25 15:45:03 UTC -0.18 0.25 9200000
HOLOGIC INC HOLX 2021-10-25 15:15:03 UTC -0.18 0.25 9200000
HOLOGIC INC HOLX 2021-10-25 14:45:02 UTC -0.1958 0.2658 9200000
HOLOGIC INC HOLX 2021-10-25 14:15:03 UTC -0.1958 0.2658 9200000
HOLOGIC INC HOLX 2021-10-25 13:45:03 UTC -0.1958 0.2658 9200000
HOLOGIC INC HOLX 2021-10-25 13:15:03 UTC -0.1958 0.2658 9200000
HOLOGIC INC HOLX 2021-10-25 12:45:04 UTC -0.1958 0.2658 9200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Absolute 500 Core Fund HOLX -63.0 shares, $-2211.3 2020-03-31 N-PORT
M3Sixty Funds Trust- AXS Market Neutral Fund HOLX -1256.0 shares, $-91474.48 2020-12-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund HOLX -1709.0 shares, $-127115.42 2021-03-31 N-PORT
AdvisorShares Trust- AdvisorShares Dorsey Wright Short ETF HOLX -3900.0 shares, $-260208.0 2021-06-30 N-PORT
AGF Investments Trust- AGFIQ Hedged Dividend Income Fund HOLX -117.0 shares, $-7806.24 2021-06-30 N-PORT

Elevate your investments